. 2019 Mar 12;10(4):950–956. doi: 10.1111/1759-7714.13034
© 2019 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Figure 3.
Overall survival (OS) in anti‐PD‐1 and chemotherapy cohorts.